Fiore Michael Henry 4

What Happened
Michael H. Fiore, EVP & Chief Commercial Officer of HealthEquity, was granted 17,582 restricted stock units (RSUs) on March 25, 2026. The Form 4 shows the award as an acquisition (code A) at $0.00 (no cash paid). These RSUs are contingent rights to receive common stock if and when they vest and are not immediately sellable shares.

Key Details

• Transaction date: 2026-03-25 (filed with the SEC on 2026-03-27).
• Transaction type/code: Award/Grant (A).
• Shares granted: 17,582 RSUs; reported acquisition price: $0.00.
• Shares owned after transaction: Not specified in the provided filing.
• Footnote (vesting): 25% of the award vests April 1, 2027; then 6.25% vests on the first day of each calendar quarter for the following 12 quarters (per footnote F1).
• Filing timeliness: Filed two days after the grant date (appears timely).

Context: RSUs represent a contingent right to receive shares upon vesting; they do not constitute an immediate purchase or sale and therefore are not a direct market sentiment signal. The award will convert to actual shares only as portions vest per the schedule above.